Daily as of 3 Nov 16:00 ET
- Price
- above both $183.88 vs 50 $165.23 / 200 $180.13
- Projection
- ๐จGolden cross estimated in 20 to 30 bars
- Test
- No active test
- Last cross
- ๐Death cross 9 Jul 2026 ยท projected 3 bars out
AstraZeneca (AZN) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.
Right now the daily is the chart to watch. The 50 SMA has sat below the 200 since Jul 2026, but the two have been closing on each other and a golden cross is projected within 30 bars. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 9 Jul 2026 | ๐Death moderate | daily | 3 bars out | Not tested |
| 13 May 2026 | ๐Death | 4-hour | 28 bars out | Not tested |
| 1 Aug 2025 | ๐จGolden | 4-hour | 24 bars out | โ |
| 23 Jul 2025 | ๐จGolden flat | daily | 18 bars out | Not tested |
| 23 Apr 2025 | ๐Death | 4-hour | 24 bars out | โ |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.